Eklivan

Eklivan (Somatostatin) is a peptide hormone used for various therapeutic purposes, including hormone regulation and symptom control. This intravenous medication is manufactured by Novendia Pharmaceuticals Ltd in the EU.

Eklivan is primarily used to manage symptoms related to hormone-secreting tumors, such as carcinoid syndrome. It helps regulate the release of certain hormones in the body, which can alleviate symptoms like diarrhea and flushing. Additionally, it may be used in other conditions where hormone regulation is necessary.

Common effects of Eklivan may include a reduction in hormone-related symptoms such as diarrhea and flushing. Some individuals might experience side effects, which can vary depending on the specific condition being treated and individual response to the medication.

Eklivan should be administered under medical supervision due to its intravenous route. It is important to follow the prescribed guidelines and monitor for any adverse reactions. Patients with certain medical conditions or allergies should inform their healthcare provider before use.

Eklivan may interact with other medications, particularly those that affect hormone levels or are metabolized by similar pathways. It is advisable to consult a healthcare professional about potential interactions, especially with other intravenous medications or supplements.